-
Mashup Score: 15More on Munich and the 25th Annual International AIDS Conference - 5 month(s) ago
Longtime readers may note the absence of this year’s Really Rapid Review™ (RRR) of the latest big HIV conference, the one that just happened in Munich. These RRR posts have been a regular on this site for a gazillion years, give or take a few, with a brief break during the peak of the pandemic. My […]
Source: blogs.jwatch.orgCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 16Learning the Names of HIV Drugs Is Horribly Difficult -- Here's Why - 5 month(s) ago
Happens every time. We start teaching about HIV, and at first, everything is going great. Epidemiology, pathogenesis, diagnosis, clinical presentation. The students are right there with us. However, then we start covering treatment — and things immediately get tricky. Because no matter how engaged and brilliant they are, and no matter how scintillating we are, when the long […]
Source: blogs.jwatch.orgCategories: General Medicine News, General HCPsTweet-
Perhaps we just want to keep it all as confusing as possible, so keep switching the names and abbreviations. https://t.co/UL3luJYMwV
-
-
Mashup Score: 449
Yesterday, at the 2024 AIDS Conference in Munich, we experienced one of those thrilling moments you always hope for when attending a scientific conference. Dr. Linda-Gail Bekker, speaking on behalf of the study investigators, presented the data on the PURPOSE-1 study of HIV prevention using twice-yearly injectable lenacapavir; results were simultaneously published in the New England […]
Source: blogs.jwatch.orgCategories: General Medicine News, HIV/AIDSTweet-
Yesterday, at the International AIDS Conference (#AIDS2024) in Munich, we got one of those thrilling moments you hope for when attending a scientific conference -- but don't usually get! Here's what happened. @LindaGailBekker @drmoupali https://t.co/dAV7LvUMCj
-
-
Mashup Score: 51
Yesterday, at the 2024 AIDS Conference in Munich, we experienced one of those thrilling moments you always hope for when attending a scientific conference. Dr. Linda-Gail Bekker, speaking on behalf of the study investigators, presented the data on the PURPOSE-1 study of HIV prevention using twice-yearly injectable lenacapavir; results were simultaneously published in the New England […]
Source: blogs.jwatch.orgCategories: General Medicine News, HIV/AIDSTweet-
Yesterday, at the International AIDS Conference (#AIDS2024) in Munich, we got one of those thrilling moments you hope for when attending a scientific conference -- but don't usually get! Here's what happened. @LindaGailBekker @drmoupali https://t.co/dAV7LvUMCj
-
-
Mashup Score: 150
Back in the early 2000s, I heard about a local hospital that eliminated contact precautions while caring for patients with methicillin-resistant Staphylococcus aureus (MRSA). No more required gowns and gloves, or warning signs on the doors, or private rooms for patients known to have MRSA. They planned to track MRSA cases carefully over the next […]
Source: blogs.jwatch.orgCategories: General Medicine News, General HCPsTweet-
Tackling this controversial issue in hospital infection control. With thanks to @dr_dmorgan @dan_diekema @ShiraDoronMD and @Josh_S_Davis and others ... Should We Continue to Use Contact Precautions for Patients with MRSA? https://t.co/eMubMprw9r
-
-
Mashup Score: 140
Back in the early 2000s, I heard about a local hospital that eliminated contact precautions while caring for patients with methicillin-resistant Staphylococcus aureus (MRSA). No more required gowns and gloves, or warning signs on the doors, or private rooms for patients known to have MRSA. They planned to track MRSA cases carefully over the next […]
Source: blogs.jwatch.orgCategories: General Medicine News, General HCPsTweet-
Tackling this controversial issue in hospital infection control. With thanks to @dr_dmorgan @dan_diekema @ShiraDoronMD and @Josh_S_Davis and others ... Should We Continue to Use Contact Precautions for Patients with MRSA? https://t.co/eMubMprw9r
-
-
Mashup Score: 80Early Heatwave ID Link-o-Rama - 7 month(s) ago
We’ll get to the links in a moment, but first, a little poll. You might have heard that there’s a new Editor-in-Chief at NEJM Journal Watch, Dr. Raja-Elie Abdulnour. We met recently, and discussed this column or blog or newsletter or whatever you want to call it. A topic came up that we’ve been wondering about […]
Source: blogs.jwatch.orgCategories: General Medicine News, General HCPsTweet-
There's so much great ID/HIV research out recently that it called out for an ID Link-o-Rama -- with the exciting news from the lenacapavir PrEP study in the poll position. Plus, a reader poll -- who are you? https://t.co/4CvX0SD67a
-
-
Mashup Score: 79Early Heatwave ID Link-o-Rama - 7 month(s) ago
We’ll get to the links in a moment, but first, a little poll. You might have heard that there’s a new Editor-in-Chief at NEJM Journal Watch, Dr. Raja-Elie Abdulnour. We met recently, and discussed this column or blog or newsletter or whatever you want to call it. A topic came up that we’ve been wondering about […]
Source: blogs.jwatch.orgCategories: General Medicine News, General HCPsTweet-
There's so much great ID/HIV research out recently that it called out for an ID Link-o-Rama -- with the exciting news from the lenacapavir PrEP study in the poll position. Plus, a reader poll -- who are you? https://t.co/4CvX0SD67a
-
-
Mashup Score: 87
Last week, we had a real treat for our weekly ID/HIV clinical conference — a review of controversies in the management of syphilis in adults by Dr. Khalil Ghanem, from Johns Hopkins. He’s a well-known expert in the field of sexually transmitted infections, syphilis in particular. A highlight of the talk was his dismantling of a […]
Source: blogs.jwatch.orgCategories: General Medicine News, General HCPsTweet-
Even the @CDCgov STI guidelines acknowledge uncertainty in how to manage serologic non-response in syphilis -- that stubborn RPR that doesn't decline. Here's a bold proposal for a clinical trial. Any takers? (h/t Dr. Khalil Ganem) https://t.co/uxm3aaPMoo
-
-
Mashup Score: 48More on ID Doctors and Primary Care for People with HIV - 7 month(s) ago
A recently published study suggested that “non-ID doctors do better” when it comes to providing primary care to people with HIV. At least that was the attention-grabbing subject line of an email summary distributed by a local primary care doctor, Dr. Geoffrey Modest. He periodically sends around detailed descriptions of studies he finds interesting, then […]
Source: blogs.jwatch.orgCategories: General Medicine News, General HCPsTweet-
A summary of a recent study wrote, “non-ID doctors do better” when providing primary care to people with HIV. Not sure the study shows that. But as I write here, who can get a primary care doctor these days anyway? Latest on this issue. https://t.co/h1slMaV7ro
-
Back from the International AIDS Society meeting in Munich, @PaulSaxMD shares some thoughts about the conference and hotel showers: https://t.co/oWijTPHc8p #IADS2024 #IDTwitter https://t.co/m93Tbnpyfz